Targeted Therapy for Hepatocellular Carcinoma: What`s New?
Journal Title: Liver Research – Open Journal - Year 2015, Vol 1, Issue 1
Abstract
Hepatocellular carcinoma (HCC), one of the most frequent neoplasms worldwide, causes more than 700,000 deaths per year, and is the third cause of cancer-related mortality.1-3 HCC occurs after years of damage to hepatocytes with inflammatory conditions due to Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV) infection resulting in chronic hepatitis and/ or cirrhosis. The disease incidence is decreasing due to Hepatitis B Virus (HBV) vaccination, whereas rates are steadily increasing in Europe and United States possibly due to increased obesity and Hepatitis C Virus (HCV) infection.3The latest antiviral drug, Sofosbuvir (Sovaldi, Gilead), has achieved notable success in clinical trials and approved against HCV and gives great hopes for treatment and hopefully preventing HCV induced liver cancer. Unfortunately, other risk factors like alcohol abuse, fungal toxins, obesity, and poor diet are also associated with HCC and will not be easily wiped out anytime soon.
Authors and Affiliations
Haluk Yuzugullu
Keywords
Related Articles
- EP ID EP556413
- DOI 10.17140/LROJ-1-e001
- Views 138
- Downloads 0
Comparisons between Portosystemic Shunting Modalities in Patients with Liver Cirrhosis and Portal Hypertension
During almost half of century period, in the Department of Surgery of Portal Hypertension and Pancreatoduodenal Zone of the JSC “Republican Specialized Center of Surgery (named after Academician V. Vakhidov”), portosyste...
Hepatitis C Update
The pace of Hepatitis C Virus (HCV) drug development in recent years has accelerated dramatically. But, for patients to benefit from these impressive advances, practitioners (i.e. “us”) need to know the most recent and a...
Magnetic Resonance Elastography Comes of Age
Clinicians are always in search of a less invasive method of diagnosing and assessing a patient. Patients with liver cirrhosis are no exception. Liver cirrhosis is the end stage of many liver pathologies and knowledge of...
Cardiovascular Disease and NASH
Non-alcoholic fatty liver disease (NAFLD) and Non-alcoholic steatohepatitis (NASH) are associated with cardiovascular events and Metabolic Syndrome (MetS). NAFLD is considered to be a hepatic manifestation of MetS and ha...
Iron and Copper Toxicity in Rat Liver: A Kinetic and Holistic Overview
Iron (Fe) and copper (Cu) overloads in rats showed a dose and time dependent metal accumulation in liver with its associated toxicity. The increased contents of the transition metals markedly enhanced the endogenous free...